• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Green Mountain Power

Green Mountain Power

  1. QS Pharma Receives Approval from European Medicines Agency for Commercial Manufacture

    QS Pharma Receives Approval from European Medicines Agency for Commercial Manufacture

  2. One Day GMP's in Practice Course: Quality Systems, Common Sense Compliance, and Application (Tampa, FL, United States - December 7, 2017) - Research and Markets

    One Day GMP's in Practice Course: Quality Systems, Common Sense Compliance, and Application (Tampa, FL, United States - December 7, 2017) - Research and Markets

  3. Two Day Seminar: How to Write Error Free Procedures and Comply with GMP Regulations (Tampa, FL, United States - October 19th-20th, 2017) - Research and Markets

    Two Day Seminar: How to Write Error Free Procedures and Comply with GMP Regulations (Tampa, FL, United States - October 19th-20th, 2017) - Research and Markets

  4. UPDATE: This giant battery is what's been missing in the renewable-energy revolution

    UPDATE: This giant battery is what's been missing in the renewable-energy revolution

  5. UPDATE: This giant battery is what's been missing in the renewable-energy revolution

    UPDATE: This giant battery is what's been missing in the renewable-energy revolution

  6. NEO Connect Eclipses $200 Million in AUM of Transacted Funds

    NEO Connect Eclipses $200 Million in AUM of Transacted Funds

  7. Eurofins Expands Its Footprint in the Balkan Region with the Acquisition of Environmental Research & Industrial Co-Operation in Slovenia

    Eurofins Expands Its Footprint in the Balkan Region with the Acquisition of Environmental Research & Industrial Co-Operation in Slovenia

  8. TxCell Appoints Lentigen Technology, Inc. To Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection

    TxCell Appoints Lentigen Technology, Inc. To Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection

  9. Cell Medica Acquires WT1 Cancer Immunotherapy from Cell and Gene Therapy Catapult

    Cell Medica Acquires WT1 Cancer Immunotherapy from Cell and Gene Therapy Catapult

12345

©2017 Morningstar Advisor. All right reserved.